2393 Stock Overview
An investment holding company, manufactures and sells medical imaging products in Mainland China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Yestar Healthcare Holdings Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.069 |
| 52 Week High | HK$0.23 |
| 52 Week Low | HK$0.016 |
| Beta | 0.10 |
| 11 Month Change | -11.54% |
| 3 Month Change | 15.00% |
| 1 Year Change | -56.88% |
| 33 Year Change | -94.44% |
| 5 Year Change | -94.93% |
| Change since IPO | -82.53% |
Recent News & Updates
These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Nov 21
Yestar Healthcare Holdings' (HKG:2393) Attractive Earnings Are Not All Good News For Shareholders
Sep 19Recent updates
These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Nov 21Yestar Healthcare Holdings' (HKG:2393) Attractive Earnings Are Not All Good News For Shareholders
Sep 19Yestar Healthcare Holdings (HKG:2393) Seems To Be Using A Lot Of Debt
Dec 13These Return Metrics Don't Make Yestar Healthcare Holdings (HKG:2393) Look Too Strong
Oct 18Is Yestar Healthcare Holdings (HKG:2393) Using Too Much Debt?
Sep 05One Yestar Healthcare Holdings Company Limited (HKG:2393) Analyst Has Been Cutting Their Forecasts
Sep 05Returns On Capital At Yestar Healthcare Holdings (HKG:2393) Have Hit The Brakes
Jun 10These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Apr 18What Kind Of Investors Own Most Of Yestar Healthcare Holdings Company Limited (HKG:2393)?
Mar 15The Returns At Yestar Healthcare Holdings (HKG:2393) Provide Us With Signs Of What's To Come
Feb 07A Look At Yestar Healthcare Holdings' (HKG:2393) Share Price Returns
Dec 21Do Institutions Own Yestar Healthcare Holdings Company Limited (HKG:2393) Shares?
Nov 30
Shareholder Returns
| 2393 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -5.5% | -3.5% | -0.6% |
| 1Y | -56.9% | -39.2% | 9.6% |
Return vs Industry: 2393 underperformed the Hong Kong Medical Equipment industry which returned -39.2% over the past year.
Return vs Market: 2393 underperformed the Hong Kong Market which returned 9.6% over the past year.
Price Volatility
| 2393 volatility | |
|---|---|
| 2393 Average Weekly Movement | 33.2% |
| Medical Equipment Industry Average Movement | 9.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.2% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 2393's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2393's weekly volatility (33%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 726 | Changxiang Liao | www.yestarcorp.com |
Yestar Healthcare Holdings Company Limited, an investment holding company, manufactures and sells medical imaging products in Mainland China. It operates through two segments: Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment.
Yestar Healthcare Holdings Company Limited Fundamentals Summary
| 2393 fundamental statistics | |
|---|---|
| Market cap | HK$160.88m |
| Earnings (TTM) | HK$1.16b |
| Revenue (TTM) | HK$2.92b |
0.1x
P/E Ratio0.1x
P/S RatioIs 2393 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2393 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.71b |
| Cost of Revenue | CN¥2.29b |
| Gross Profit | CN¥426.15m |
| Other Expenses | -CN¥651.84m |
| Earnings | CN¥1.08b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.46 |
| Gross Margin | 15.70% |
| Net Profit Margin | 39.72% |
| Debt/Equity Ratio | 44.8% |
How did 2393 perform over the long term?
See historical performance and comparison